Helicobacter pylori Vaccine Development in the Post-genomic Era: Can In Silico translate to In Vivo
- 1 May 2001
- journal article
- review article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 53 (5) , 443-448
- https://doi.org/10.1046/j.1365-3083.2001.00913.x
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Immunization with Recombinant Helicobacter pylori Urease in Specific-Pathogen-Free Rhesus Monkeys ( Macaca mulatta )Infection and Immunity, 2000
- Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome SequencingScience, 2000
- Translocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV SecretionScience, 2000
- Qualitative and Quantitative Analysis of the Local and Systemic Antibody Response in Mice and Humans withHelicobacterImmunity and InfectionThe Journal of Infectious Diseases, 1999
- Antibody-Independent Protective Mucosal Immunity to Gastric Helicobacter Infection in MiceCellular Immunology, 1999
- Applications of molecular microbiology to vaccinologyThe Lancet, 1997
- Use of the complete genome sequence information of Haemophilus influenzae strain Rd to investigate lipopolysaccharide biosynthesisMolecular Microbiology, 1996
- Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infectionThe Lancet, 1996
- Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunizationVaccine, 1993
- Helicobacter pylori catalaseMicrobiology, 1991